Related Experiment Video
Updated: Aug 15, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management
Ana M Ramos-Leví1, Mónica Marazuela2
1Department of Endocrinology, Hospital Universitario La Princesa, Instituto de Investigación Princesa, Universidad Autónoma, Madrid, Spain.
Insights
Acromegaly frequently causes cardiovascular comorbidities like hypertension and cardiomyopathy, increasing mortality risk. Early screening and treatment are crucial for managing these heart conditions in acromegaly patients.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular comorbidities are highly prevalent in acromegaly patients.
- These conditions significantly increase morbidity and all-cause mortality.
- Common findings include hypertension, cardiomyopathy, arrhythmias, and coronary artery disease.
Purpose of the Study:
- To review prevalent cardiovascular comorbidities in acromegaly.
- To discuss their underlying pathophysiology.
- To provide recommendations for diagnosis, management, and treatment.
Main Methods:
- Literature review of cardiovascular complications in acromegaly.
- Discussion of physiopathological factors including growth hormone/insulin-like growth factor 1 excess.
- Analysis of diagnostic techniques and treatment effects.
Main Results:
- Cardiovascular comorbidities are frequent and multifactorial in acromegaly.
- Uncontrolled hormone excess, age, and disease duration are key influences.
- Prompt diagnosis and management can mitigate cardiac abnormalities.
Conclusions:
- Cardiovascular health is a critical concern in acromegaly management.
- A systematic approach to screening and treatment is recommended.
- Further understanding of diagnostic tools and therapeutic impacts is needed.
Abstract:
Comorbidities related to the cardiovascular system are one of the most prevalent in patients with acromegaly, and contribute to an increased risk of morbidity and all-cause mortality. Specifically, hypertension, cardiomyopathy, heart valve disease, arrhythmias, atherosclerosis, coronary artery disease, and cardiac dysfunction may be frequent findings. Although the underlying physiopathology for each comorbidity may not be fully elucidated, uncontrolled growth hormone/insulin-like growth factor 1 excess, age, prolonged disease duration, and coexistence of other cardio-vascular risk factors are significant influencing variables. A simple diagnostic approach to screen for the presence of these comorbidities may allow prompt treatment and arrest the progression of cardiac abnormalities. In this article, we revise the most prevalent cardiovascular comorbidities and their pathophysiology in acromegalic patients, and we address some recommendations for their prompt diagnosis, management and treatment. Strengths and pitfalls of different diagnostic techniques that are currently being used and how different treatments can affect these complications will be further discussed.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies

